267 related articles for article (PubMed ID: 11495083)
1. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon.
Khan KN; Masferrer JL; Woerner BM; Soslow R; Koki AT
Scand J Gastroenterol; 2001 Aug; 36(8):865-9. PubMed ID: 11495083
[TBL] [Abstract][Full Text] [Related]
2. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin expression is homogeneously reduced in adenoma from patients with familial adenomatous polyposis: an immunohistochemical study of E-cadherin, beta-catenin and cyclooxygenase-2 expression.
Jungck M; Grünhage F; Spengler U; Dernac A; Mathiak M; Caspari R; Friedl W; Sauerbruch T
Int J Colorectal Dis; 2004 Sep; 19(5):438-45. PubMed ID: 14986031
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers.
Sinicrope FA; Lemoine M; Xi L; Lynch PM; Cleary KR; Shen Y; Frazier ML
Gastroenterology; 1999 Aug; 117(2):350-8. PubMed ID: 10419916
[TBL] [Abstract][Full Text] [Related]
5. Mucosal prostanoid receptors and synthesis in familial adenomatous polyposis.
Takafuji V; Lublin D; Lynch K; Roche JK
Histochem Cell Biol; 2001 Aug; 116(2):171-81. PubMed ID: 11685545
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of cytoplasmic HuR in familial adenomatous polyposis.
Brosens LA; Keller JJ; Pohjola L; Haglund C; Morsink FH; Iacobuzio-Donahue C; Goggins M; Giardiello FM; Ristimäki A; Offerhaus GJ
Cancer Biol Ther; 2008 Mar; 7(3):424-7. PubMed ID: 18094611
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression in the hereditary mixed polyposis syndrome.
Brazowski E; Misonzhnick-Bedny F; Rozen P
Dig Dis Sci; 2004; 49(11-12):1906-11. PubMed ID: 15628724
[TBL] [Abstract][Full Text] [Related]
8. COX-2 and colon cancer.
Taketo MM
Inflamm Res; 1998 Oct; 47 Suppl 2():S112-6. PubMed ID: 9831333
[TBL] [Abstract][Full Text] [Related]
9. COX selectivity and animal models for colon cancer.
Oshima M; Taketo MM
Curr Pharm Des; 2002; 8(12):1021-34. PubMed ID: 11945149
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
Moran EM
J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
[TBL] [Abstract][Full Text] [Related]
11. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
Kennedy BP; Soravia C; Moffat J; Xia L; Hiruki T; Collins S; Gallinger S; Bapat B
Cancer Res; 1998 Feb; 58(3):500-3. PubMed ID: 9458096
[TBL] [Abstract][Full Text] [Related]
13. Size-dependent expression of cyclooxygenase-2 in sporadic colorectal adenomas relative to adenomas in patients with familial adenomatous polyposis.
Azumaya M; Kobayashi M; Ajioka Y; Honma T; Suzuki Y; Takeuchi M; Narisawa R; Asakura H
Pathol Int; 2002 Apr; 52(4):272-6. PubMed ID: 12031082
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of familial juvenile polyps expressing cyclooxygenase-2.
Brazowski E; Rozen P; Misonzhnick-Bedny F; Gitstein G
Am J Gastroenterol; 2005 Jan; 100(1):130-8. PubMed ID: 15654792
[TBL] [Abstract][Full Text] [Related]
15. COX-2 is expressed in human pulmonary, colonic, and mammary tumors.
Soslow RA; Dannenberg AJ; Rush D; Woerner BM; Khan KN; Masferrer J; Koki AT
Cancer; 2000 Dec; 89(12):2637-45. PubMed ID: 11135226
[TBL] [Abstract][Full Text] [Related]
16. [COX inhibitor, suppression of polyposis, and chemoprevention].
Oshima M; Taketo MM
Nihon Yakurigaku Zasshi; 2002 Nov; 120(5):276-84. PubMed ID: 12491803
[TBL] [Abstract][Full Text] [Related]
17. Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam.
Dobbie Z; Muller PY; Heinimann K; Albrecht C; D'Orazio D; Bendik I; Müller H; Bauerfeind P
Anticancer Res; 2002; 22(4):2215-20. PubMed ID: 12174906
[TBL] [Abstract][Full Text] [Related]
18. Cellular localization of cyclo-oxygenase isozymes in Crohn's disease and colorectal cancer.
Müller-Decker K; Albert C; Lukanov T; Winde G; Marks F; Fürstenberger G
Int J Colorectal Dis; 1999 Nov; 14(4-5):212-8. PubMed ID: 10647629
[TBL] [Abstract][Full Text] [Related]
19. Effect of sulindac treatment for attenuated familial adenomatous polyposis with a new germline APC mutation at codon 161: report of a case.
Esaki M; Matsumoto T; Mizuno M; Kobori Y; Yoshimura R; Yao T; Iida M
Dis Colon Rectum; 2002 Oct; 45(10):1397-402; discussion 1402-6. PubMed ID: 12394442
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps.
Sonoshita M; Takaku K; Oshima M; Sugihara K; Taketo MM
Cancer Res; 2002 Dec; 62(23):6846-9. PubMed ID: 12460897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
